- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.93 Å
- Oligo State
- homo-dimer
- Ligands
- 2 x GLC: alpha-D-glucopyranose(Non-covalent)
- 36 x DMS: DIMETHYL SULFOXIDE(Non-functional Binders)
DMS.2: 5 residues within 4Å:- Chain A: W.68, I.69, Q.72, R.194
- Chain B: V.41
Ligand excluded by PLIPDMS.3: 3 residues within 4Å:- Chain A: D.62, H.63
- Chain B: F.38
Ligand excluded by PLIPDMS.4: 6 residues within 4Å:- Chain A: F.203, Q.220, V.222, A.273, K.295
- Ligands: DMS.19
Ligand excluded by PLIPDMS.5: 4 residues within 4Å:- Chain A: H.202, W.216, R.352, L.357
Ligand excluded by PLIPDMS.6: 6 residues within 4Å:- Chain A: R.520, E.702, E.703, A.704, G.705, T.808
Ligand excluded by PLIPDMS.7: 5 residues within 4Å:- Chain A: E.707, F.709, F.710, R.787, M.801
Ligand excluded by PLIPDMS.8: 6 residues within 4Å:- Chain A: R.67, N.102, L.103, R.235, N.237, R.834
Ligand excluded by PLIPDMS.9: 4 residues within 4Å:- Chain A: Y.549, E.553, Y.554, R.650
Ligand excluded by PLIPDMS.10: 8 residues within 4Å:- Chain A: Q.265, L.268, D.269, N.271, L.272
- Chain B: N.271, N.275
- Ligands: DMS.29
Ligand excluded by PLIPDMS.11: 5 residues within 4Å:- Chain A: L.550, Y.554, F.645, L.646, E.647
Ligand excluded by PLIPDMS.12: 4 residues within 4Å:- Chain A: Y.727, H.768, D.770, R.771
Ligand excluded by PLIPDMS.13: 5 residues within 4Å:- Chain A: I.532, A.536, P.795, R.796, T.799
Ligand excluded by PLIPDMS.14: 5 residues within 4Å:- Chain A: P.195
- Chain B: L.184, R.185, Y.186, G.187
Ligand excluded by PLIPDMS.15: 7 residues within 4Å:- Chain A: R.428, T.467, I.468, F.469, K.470, D.471, F.472
Ligand excluded by PLIPDMS.16: 5 residues within 4Å:- Chain A: I.264, Q.265
- Chain B: Y.281, K.290, L.292
Ligand excluded by PLIPDMS.17: 5 residues within 4Å:- Chain A: Q.409, L.412, N.413, A.416, L.426
Ligand excluded by PLIPDMS.18: 0 residues within 4Å:- (No contacts)
Ligand excluded by PLIPDMS.19: 6 residues within 4Å:- Chain A: L.272, N.275, L.292, K.295
- Chain B: L.268
- Ligands: DMS.4
Ligand excluded by PLIPDMS.21: 5 residues within 4Å:- Chain A: V.41
- Chain B: W.68, I.69, Q.72, R.194
Ligand excluded by PLIPDMS.22: 3 residues within 4Å:- Chain A: F.38
- Chain B: D.62, H.63
Ligand excluded by PLIPDMS.23: 6 residues within 4Å:- Chain B: F.203, Q.220, V.222, A.273, K.295
- Ligands: DMS.38
Ligand excluded by PLIPDMS.24: 4 residues within 4Å:- Chain B: H.202, W.216, R.352, L.357
Ligand excluded by PLIPDMS.25: 6 residues within 4Å:- Chain B: R.520, E.702, E.703, A.704, G.705, T.808
Ligand excluded by PLIPDMS.26: 5 residues within 4Å:- Chain B: E.707, F.709, F.710, R.787, M.801
Ligand excluded by PLIPDMS.27: 6 residues within 4Å:- Chain B: R.67, N.102, L.103, R.235, N.237, R.834
Ligand excluded by PLIPDMS.28: 4 residues within 4Å:- Chain B: Y.549, E.553, Y.554, R.650
Ligand excluded by PLIPDMS.29: 8 residues within 4Å:- Chain A: N.271, N.275
- Chain B: Q.265, L.268, D.269, N.271, L.272
- Ligands: DMS.10
Ligand excluded by PLIPDMS.30: 5 residues within 4Å:- Chain B: L.550, Y.554, F.645, L.646, E.647
Ligand excluded by PLIPDMS.31: 4 residues within 4Å:- Chain B: Y.727, H.768, D.770, R.771
Ligand excluded by PLIPDMS.32: 5 residues within 4Å:- Chain B: I.532, A.536, P.795, R.796, T.799
Ligand excluded by PLIPDMS.33: 5 residues within 4Å:- Chain A: L.184, R.185, Y.186, G.187
- Chain B: P.195
Ligand excluded by PLIPDMS.34: 7 residues within 4Å:- Chain B: R.428, T.467, I.468, F.469, K.470, D.471, F.472
Ligand excluded by PLIPDMS.35: 5 residues within 4Å:- Chain A: Y.281, K.290, L.292
- Chain B: I.264, Q.265
Ligand excluded by PLIPDMS.36: 5 residues within 4Å:- Chain B: Q.409, L.412, N.413, A.416, L.426
Ligand excluded by PLIPDMS.37: 0 residues within 4Å:- (No contacts)
Ligand excluded by PLIPDMS.38: 6 residues within 4Å:- Chain A: L.268
- Chain B: L.272, N.275, L.292, K.295
- Ligands: DMS.23
Ligand excluded by PLIP- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Alexacou, K.M. et al., Crystallographic and computational studies on 4-phenyl-N-(beta-D-glucopyranosyl)-1H-1,2,3-triazole-1-acetamide, an inhibitor of glycogen phosphorylase: Comparison with alpha-D-glucose, N-acetyl-beta-D-glucopyranosylamine and N-benzoyl-N'-beta-D-glucopyranosyl urea binding. Proteins (2007)
- Release Date
- 2008-04-01
- Peptides
- Glycogen phosphorylase, muscle form: AB
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
A
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.93 Å
- Oligo State
- homo-dimer
- Ligands
- 2 x GLC: alpha-D-glucopyranose(Non-covalent)
- 36 x DMS: DIMETHYL SULFOXIDE(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Alexacou, K.M. et al., Crystallographic and computational studies on 4-phenyl-N-(beta-D-glucopyranosyl)-1H-1,2,3-triazole-1-acetamide, an inhibitor of glycogen phosphorylase: Comparison with alpha-D-glucose, N-acetyl-beta-D-glucopyranosylamine and N-benzoyl-N'-beta-D-glucopyranosyl urea binding. Proteins (2007)
- Release Date
- 2008-04-01
- Peptides
- Glycogen phosphorylase, muscle form: AB
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
A